DeepMind Parent: Alphabet

Primary contact
Edmonton and Montreal, Canada; Mountain View, California

DeepMind Technologies Limited is a British artificial intelligence company founded in September 2010. Acquired by Google in 2014, the company has created a neural network that learns how to play video games in a fashion similar to that of humans, as well as a Neural Turing machine, or a neural network that may be able to access an external memory like a conventional Turing machine, resulting in a computer that mimics the short-term memory of the human brain. The company made headlines in 2016 after its AlphaGo program beat a human professional Go player for the first time in October 2015 and again when AlphaGo beat Lee Sedol the world champion in a five-game match, which was the subject of a documentary film. A more generic program, AlphaZero, beat the most powerful programs playing go, chess and shogi (Japanese chess) after a few hours of play against itself using reinforcement learning. Healthcare applications In July 2016, a collaboration between DeepMind and Moorfields Eye Hospital was announced. DeepMind would be applied to the analysis of anonymised eye scans, searching for early signs of diseases leading to blindness. In August 2016, a research programme with University College London Hospital was announced with the aim of developing an algorithm that can automatically differentiate between healthy and cancerous tissues in head and neck areas. There are also projects with the Royal Free London NHS Foundation Trust and Imperial College Healthcare NHS Trust to develop new clinical mobile apps linked to electronic patient records. Staff at the Royal Free Hospital were reported as saying in December 2017 that access to patient data through the app had saved a "huge amount of time" and made a "phenomenal" difference to the management of patients with acute kidney injury. Test result data is sent to staff's mobile phones and alerts them to change in the patient's condition. It also enables staff to see if someone else has responded, and to show patients their results in visual form.
Primary contact
Edmonton and Montreal, Canada; Mountain View, California

Last update: February 8, 2018